Korro Bio (KRRO) Earnings Analysis

Korro Bio (KRRO) next reports earnings on 2026-08-11, consensus EPS -1.338 USD. Last quarter (2026-05-07) it missed with EPS -1.69 USD vs -1.6 USD est (-5.6%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -1.00.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does KRRO next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-1.338 USD
Revenue estimate0.00B

KRRO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-1.69 USD-1.6 USD-5.6%Miss
2026-03-12-5.32 USD-1.93 USD-175.6%Miss
2025-11-12-1.92 USD-2.61 USD+26.4%Beat
2025-08-12-2.74 USD-2.54 USD-7.9%Miss
2025-03-18-2.26 USD-2.33 USD+3%Beat

Beat rate: 2/5 (40%) over reported quarters with consensus data.

KRRO valuation and analyst view

Trailing P/E-1.00
Trailing EPS-9.78539 USD
Price / book1.13
Dividend yield0.00%
Market cap0.12B
Analyst consensusBuy (10 buy / 2 hold / 0 sell)
Avg price target15 USD

Related research pages

Frequently asked questions

When is Korro Bio (KRRO)'s next earnings date?

Korro Bio is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -1.338 USD and revenue estimate of 0.00B.

Did KRRO beat earnings last quarter?

In its 2026-05-07 report, KRRO posted EPS of -1.69 USD versus a -1.6 USD estimate — a miss of 5.6%.

What is KRRO's earnings track record?

Over the last 5 reported quarters with consensus data, KRRO beat estimates 2 times (40%).

What is KRRO's current P/E ratio and EPS?

KRRO trades at a trailing P/E of -1.00 on trailing EPS of -9.785392642996635 USD.

What do analysts rate KRRO?

Analyst consensus is "Buy" across 12 ratings (0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 15 USD.